| 1 |
33413061 | Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis? | 2021 |
1 |
| 2 |
34564325 | Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon. | 2021 Aug 31 |
1 |
| 3 |
31904280 | Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy. | 2020 Feb 1 |
1 |
| 4 |
32612429 | Determination of Endothelial Nitric Oxide Synthase Gene Polymorphism and Plasma Asymmetric Dimethyl Arginine Concentrations in Patients with Lung Cancer. | 2020 Jun |
1 |
| 5 |
32814314 | Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension. | 2020 |
1 |
| 6 |
32935809 | The effect of nitric oxide, endothelial nitric oxide synthetase, and asymmetric dimethylarginine in hemorrhoidal disease. | 2020 Aug |
1 |
| 7 |
29372262 | Vascular endothelium dysfunction: a conservative target in metabolic disorders. | 2018 May |
1 |
| 8 |
30256050 | Asymmetric dimethylarginine and angiogenesis: biological significance. | 2018 Dec |
1 |
| 9 |
28337882 | Correlation between blood asymmetric dimethylarginine level and the complications of patients with cardiovascular diseases. | 2017 Jan-Mar |
1 |
| 10 |
28562663 | Cellular interactions between L-arginine and asymmetric dimethylarginine: Transport and metabolism. | 2017 |
1 |
| 11 |
26759218 | Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease. | 2016 |
1 |
| 12 |
26959555 | Asymmetric Dimethylarginine Stimulates Akt1 Phosphorylation via Heat Shock Protein 70-Facilitated Carboxyl-Terminal Modulator Protein Degradation in Pulmonary Arterial Endothelial Cells. | 2016 Aug |
1 |
| 13 |
27091343 | Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase. | 2016 Apr 18 |
1 |
| 14 |
27175806 | High salt medium activates RhoA/ROCK and downregulates eNOS expression via the upregulation of ADMA. | 2016 Jul |
1 |
| 15 |
27345001 | Association between Asymmetric Dimethylarginine and Pentosidine in Dialysis Effluent of Peritoneal Dialysis Patients -A possible intraperitoneal crosstalk between asymmetric dimethylarginine and advanced glycation end products in peritoneal dialysis patients. | 2016 Jun 20 |
1 |
| 16 |
27417628 | Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline? | 2016 Jul 8 |
3 |
| 17 |
26091577 | Asymmetric dimethyl arginine induces pulmonary vascular dysfunction via activation of signal transducer and activator of transcription 3 and stabilization of hypoxia-inducible factor 1-alpha. | 2015 Oct |
3 |
| 18 |
26354377 | Endothelial dysfunction in subjects with chronic cadmium exposure. | 2015 |
1 |
| 19 |
26385052 | Pharmacogenetic influence of eNOS gene variant on endothelial and glucose metabolism responses to L-arginine supplementation: Post hoc analysis of the L-arginine trial. | 2015 Nov |
1 |
| 20 |
26527496 | Effect of protein arginine methyltransferase-1 inhibition on hypoxia-induced vasoconstriction. | 2015 Dec |
1 |
| 21 |
24469026 | Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection. | 2014 Feb 20 |
1 |
| 22 |
25210424 | Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration. | 2014 |
1 |
| 23 |
23255608 | Asymmetric dimethylarginine induces endothelial nitric-oxide synthase mitochondrial redistribution through the nitration-mediated activation of Akt1. | 2013 Mar 1 |
1 |
| 24 |
23448493 | Endothelial dysfunction in morbid obesity. | 2013 |
2 |
| 25 |
23711612 | Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individuals. | 2013 Jul |
1 |
| 26 |
23825361 | Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. | 2013 Aug 20 |
1 |
| 27 |
20926145 | The impact of rapid atrial pacing on ADMA and endothelial NOS. | 2012 Jan 26 |
1 |
| 28 |
22297680 | Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. | 2012 Apr |
1 |
| 29 |
22538734 | Relationship between serum asymmetric dimethylarginine and left ventricular structure and function in patients with end‑stage renal disease treated with hemodialysis. | 2012 |
1 |
| 30 |
22558392 | A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. | 2012 |
1 |
| 31 |
26105457 | PP135. Maternal serum levels of endothelial nitric oxide synthase and ADMA, an endogenous ENOS inhibitor in pregnancies complicated by severe preeclampsia. | 2012 Jul |
1 |
| 32 |
21644402 | Plasma asymmetric dimethylarginine levels in healthy people. | 2011 Jan-Mar |
1 |
| 33 |
20382774 | Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus. | 2010 Apr |
1 |
| 34 |
19297385 | Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. | 2009 May |
2 |
| 35 |
19331593 | Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease. | 2009 Mar |
1 |
| 36 |
19332631 | Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis. | 2009 May |
1 |
| 37 |
19486510 | A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria. | 2009 Jun 1 |
1 |
| 38 |
19644064 | Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study. | 2009 Sep |
1 |
| 39 |
19803415 | The emerging role of symmetric dimethylarginine in vascular disease. | 2009 |
1 |
| 40 |
19809994 | Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients. | 2009 Sep-Oct |
1 |
| 41 |
18385287 | Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. | 2008 Jun |
1 |
| 42 |
18792879 | Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance. | 2008 Sep |
1 |
| 43 |
17357445 | [The pathogenic mechanism of homocysteine -induced endothelial nitric oxide synthase dysfunction and the antagonistic effects by folic acid]. | 2007 Feb |
2 |
| 44 |
17406107 | Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis. | 2007 |
1 |
| 45 |
17505150 | Asymmetric dimethylarginine levels in thyroid diseases. | 2007 Mar |
1 |
| 46 |
17977009 | Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity. | 2007 Dec |
1 |
| 47 |
18167189 | Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene. | 2007 Dec 5 |
1 |
| 48 |
16009421 | Reduced L-arginine level and decreased placental eNOS activity in preeclampsia. | 2006 Apr-May |
2 |
| 49 |
16384887 | Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilic-interaction liquid chromatography-electrospray tandem mass spectrometry. | 2006 Mar |
1 |
| 50 |
16148605 | The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease. | 2005 Oct |
1 |